SI2167085T1 - 4- š2- (4-methylphenylsulfanyl) phenylćpiperidine for the treatment of irritable bowel syndrome (ibs) - Google Patents

4- š2- (4-methylphenylsulfanyl) phenylćpiperidine for the treatment of irritable bowel syndrome (ibs)

Info

Publication number
SI2167085T1
SI2167085T1 SI200831137T SI200831137T SI2167085T1 SI 2167085 T1 SI2167085 T1 SI 2167085T1 SI 200831137 T SI200831137 T SI 200831137T SI 200831137 T SI200831137 T SI 200831137T SI 2167085 T1 SI2167085 T1 SI 2167085T1
Authority
SI
Slovenia
Prior art keywords
phenylćpiperidine
methylphenylsulfanyl
ibs
treatment
bowel syndrome
Prior art date
Application number
SI200831137T
Other languages
Slovenian (sl)
Inventor
Silke Miller
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/DK2007/050076 external-priority patent/WO2007144006A1/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Priority claimed from EP08758225.0A external-priority patent/EP2167085B1/en
Publication of SI2167085T1 publication Critical patent/SI2167085T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SI200831137T 2007-06-15 2008-06-13 4- š2- (4-methylphenylsulfanyl) phenylćpiperidine for the treatment of irritable bowel syndrome (ibs) SI2167085T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/DK2007/050076 WO2007144006A1 (en) 2006-06-16 2007-06-15 Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
PCT/DK2008/000216 WO2008151632A1 (en) 2007-06-15 2008-06-13 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine for the treatment of irritable bowel syndrome (ibs)
EP08758225.0A EP2167085B1 (en) 2007-03-20 2008-06-13 4- [2- (4-methylphenylsulfanyl) phenyl]piperidine for the treatment of irritable bowel syndrome (ibs)

Publications (1)

Publication Number Publication Date
SI2167085T1 true SI2167085T1 (en) 2014-05-30

Family

ID=39755623

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200831137T SI2167085T1 (en) 2007-06-15 2008-06-13 4- š2- (4-methylphenylsulfanyl) phenylćpiperidine for the treatment of irritable bowel syndrome (ibs)

Country Status (4)

Country Link
JP (1) JP5764327B2 (en)
HR (1) HRP20140044T1 (en)
SI (1) SI2167085T1 (en)
WO (1) WO2008151632A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200938194A (en) * 2007-12-14 2009-09-16 Lundbeck & Co As H Therapeutic uses of compounds having affinity to the serotonin transporter, serotonin receptors and noradrenalin transporter

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (en) * 2001-10-04 2008-02-11 Х. Луннбек А/С Derivated of phenylpiperazine as serotonin reuptake inhibitorS
PL2044020T3 (en) 2006-06-16 2011-09-30 H Lundbeck As Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain
TWI432194B (en) * 2007-03-20 2014-04-01 Lundbeck & Co As H Novel therapeutic uses of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine
TWI405588B (en) * 2007-03-20 2013-08-21 Lundbeck & Co As H Liquid formulations of salts of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine

Also Published As

Publication number Publication date
WO2008151632A1 (en) 2008-12-18
JP2010529968A (en) 2010-09-02
HRP20140044T1 (en) 2014-02-14
JP5764327B2 (en) 2015-08-19

Similar Documents

Publication Publication Date Title
PL2252148T3 (en) Methods for treating irritable bowel syndrome
HK1143541A1 (en) Method for treatment of constipation-predominant irritable bowel syndrome
PT2034844T (en) Method for treatment of diarrhea-predominant irritable bowel syndrome
ZA200902374B (en) Compositions useful for the treatment of diabetes
HK1148435A1 (en) Oxadiazoanthracene compounds for the treatment of diabetes
HK1139860A1 (en) Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome
ZA201006827B (en) Carboxamide-heteroaryl derivatives for the treatment of diabetes
EP2295125A4 (en) Solution condensing apparatus
GB0817067D0 (en) Intestinal treatment
EP2276491A4 (en) New therapy of treatment of the irritable bowel syndrome.
EP1872795A4 (en) Therapeutic agent for irritable bowel syndrome
EP2475392A4 (en) Methods for treating irritable bowel syndrome (ibs)
EP2071717A4 (en) Inverter apparatus
IL196602A0 (en) Processes for the preparation of montelukast
EP2358200A4 (en) Substituted bicyclic amines for the treatment of diabetes
EP2174956A4 (en) Compositions for anti-fibrinolitic treatment
EP2433638A4 (en) Composition for preventing or treating irritable bowel syndrome
EP2322222A4 (en) Therapeutic agent for irritable bowel syndrome
PL2176002T3 (en) Cyclone apparatus
SI2167085T1 (en) 4- š2- (4-methylphenylsulfanyl) phenylćpiperidine for the treatment of irritable bowel syndrome (ibs)
IL193686A0 (en) Agent for prevention/treatment of irritable bowel syndrome
GB0819518D0 (en) Compounds for the treatment of flaviviral infections
GB0817437D0 (en) Compounds for the treatment of flaviviral infections
GB0814216D0 (en) Compounds for the treatment of flaviviral infections
AU2005905684A0 (en) Compounds for the treatment of irritable bowel syndrome